Manufacturer Argues Xarelto Should Be Used Over Coumadin Despite Lack of Antidote

Gabriel A. Assaad
Partner Gabriel Assaad represents victims of negligence and medical malpractice nationwide.
Comments (0)

For years, when a patient faced a risk of blood clotting or stroke, they were prescribed Coumadin to thin their blood. While the drug was largely successful, it also requires ongoing patient monitoring. Manufacturers of the drug Xarelto sold their medication to physicians and patients by touting the benefits of the drug’s lack of required monitoring. Unfortunately, these benefits were touted while the risk of dangerous side effects were minimized. Many patients have since gone on to suffer severe and sometimes fatal injuries as a result.

Manufacturer’s Alleged Benefits of Xarelto Use May Have Misled Many

How did the manufacturers of Xarelto persuade doctors and patients to move away from Coumadin and instead prescribe Xarelto? The following is an overview:

  1. Xarelto was designed to prevent strokes and blood clots after knee or hip surgery.
     
  2. Xarelto’s main competitor, Coumadin, also known as Warfarin, requires regular blood monitoring for patients using the medication. This monitoring is designed to ensure that patients stay within the therapeutic levels for the drug.
     
  3. Patients taking Coumadin who move outside of the therapeutic range for the drug have to have their medication dosage adjusted either up or down.
     
  4. Coumadin patients require regular doctor visits as a result.
     
  5. Xarelto uses a different mechanism for preventing blood clots. Its makers do not call for ongoing monitoring of patients using the drug.

Unfortunately, little mention is made of the dangerous side effects linked to blood thinners, which is internal bleeding. Patients taking Coumadin have the advantage of a readily available antidote. These patients can be given vitamin K or fresh frozen plasma to reverse the effects of the internal bleeding. Patients using Xarelto, however, have no such antidote available. This significantly raises the risk of internal bleeding or even death should internal bleeding occur. An added disadvantage of this drug is its cost. Patients pay around $250 – $300 per month for Xarelto, whereas Warfarin typically costs 50 cents per day.

If you or a loved one suffered an injury after taking Xarelto, you have legal rights and we are here to help. We encourage you to reach out today for a free consultation at 855-947-0707.

 

Be the first to comment!

Post a Comment

To reply to this message, enter your reply in the box labeled "Message", hit "Post Message."

Name:*

Email:* (will not be published)

Message:*

Notify me of follow-up comments via email.